chr1-16026235-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004070.4(CLCNKA):c.486C>T(p.Phe162=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,613,862 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 14 hom. )
Consequence
CLCNKA
NM_004070.4 synonymous
NM_004070.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.323
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-16026235-C-T is Benign according to our data. Variant chr1-16026235-C-T is described in ClinVar as [Benign]. Clinvar id is 447088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.323 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00562 (856/152200) while in subpopulation AFR AF= 0.0197 (817/41532). AF 95% confidence interval is 0.0186. There are 9 homozygotes in gnomad4. There are 391 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKA | NM_004070.4 | c.486C>T | p.Phe162= | synonymous_variant | 5/20 | ENST00000331433.5 | NP_004061.3 | |
CLCNKA | NM_001042704.2 | c.486C>T | p.Phe162= | synonymous_variant | 5/20 | NP_001036169.1 | ||
CLCNKA | NM_001257139.2 | c.357C>T | p.Phe119= | synonymous_variant | 4/19 | NP_001244068.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCNKA | ENST00000331433.5 | c.486C>T | p.Phe162= | synonymous_variant | 5/20 | 1 | NM_004070.4 | ENSP00000332771 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00560 AC: 852AN: 152082Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
852
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00149 AC: 373AN: 251140Hom.: 4 AF XY: 0.00108 AC XY: 147AN XY: 135792
GnomAD3 exomes
AF:
AC:
373
AN:
251140
Hom.:
AF XY:
AC XY:
147
AN XY:
135792
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000687 AC: 1004AN: 1461662Hom.: 14 Cov.: 33 AF XY: 0.000596 AC XY: 433AN XY: 727114
GnomAD4 exome
AF:
AC:
1004
AN:
1461662
Hom.:
Cov.:
33
AF XY:
AC XY:
433
AN XY:
727114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00562 AC: 856AN: 152200Hom.: 9 Cov.: 32 AF XY: 0.00526 AC XY: 391AN XY: 74386
GnomAD4 genome
AF:
AC:
856
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
391
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 15, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at